12:15 PM EST - Microbix Biosystems Inc. : Reports financial results for its third quarter of fiscal 2018, the three-month period ending June 30, 2018, with record sales and progress toward its operational goals. Total Q3 revenue was $3,235,224, a 17% increase over 2017 third-quarter revenue of $2,773,365. Included were antigen and quality product revenues of $3,158,058, 17% higher than 2017 due largely to strong Asian growth via our distribution partner. Revenue from royalties were $77,166 (2017 - $67,954). In total, Microbix generated positive Q3 net operating income before restructuring and tax adjustments of $958, versus a loss of $164,104 in 2017. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.25.
